Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded with the volume of 2.07 Million Yesterday. The Stock Opened its session at $48.01 and closed at $46.25 by showing an decrease of -3.16 percent. Acadia Healthcare Company, Inc. has 1 year price target of 73.4. The stock gained a consensus recommendation of 1.31 on Zacks Investment Research where the scale runs from 1 to 5, 1 representing Strong buy and 5 showing Strong Sell. The company is expected to report its next EPS (earnings per share) on Nov 03 AMC. The company reported its last quarter on Jun 16.
On Jun 16 Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reported its EPS in the last quarter as $0.73/Share lagging the analyst estimate of $0.73/Share by the difference of $0. This showed the surprise of 0% in the last quarter earnings. For the Current Quarter, 8 analyst are projecting the mean EPS to be $0.71/share. According to their observations and findings, the stock could provide a high EPS of $0.8/share and a Low EPS of $0.64/share.
The 16 analysts offering 12-month price forecasts for Acadia Healthcare Company Inc have a median target of 71.00, with a high estimate of 85.00 and a low estimate of 61.00. The median estimate represents a +53.51% increase from the last price of 46.25. (CNN MONEY)
Many Analysts provided their foresight on Revenue Estimates of Acadia Healthcare Company, Inc. where they believe that the company has the potential to earn average revenue of $748.01 Million for the current quarter. According to their predictions High & Low revenue estimates are 782.5 Million and 718.9 Million respectively.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) topped its 52-week high price of $74.77 on Nov 6, 2015 and 52-Week Low Price of $45.85 on Oct 7, 2016. The Stock currently has the market capitalization of $4.17 Million, P/E (price to earnings ttm) of 25.27 and Weekly volatility of 2.93%% and monthly volatility of 3.25%% respectively.
Acadia Healthcare Company, Inc. is currently showing 17.9% EPS growth this year. The Next Year EPS growth is 20.2%, Long term annual growth estimate of 19.1%, Annual EPS growth past 5 years of 47.62 percent. The Company currently has Insider ownership of 1.2 Percent and Institutional Ownership of 80 Percent. The Return on Assets stands at 2.7%, Return on Equity shows 7% and Return on Investment value is 5.6%.
Acadia Healthcare Company, Inc. Gross Margin percentage stands at 0% while its Operating Margin for trailing twelve month is 14.6 percent and Profit margin (ttm) is 6.2 Percent. The stock is currently moving above its 20-Day Simple Moving Average of -9.5% with the 50-Day Simple Moving Average of -9.5 percent. Currently, the company has SMA200 (200-day simple moving average) of -17.35 Percent. The Stock has YTD (year to date) performance of -25.95 percent.
Many research firms have provided their ratings on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) where KeyBanc Capital Mkts provided Overweightrating on the stock on 1-Feb-16. Other firms include JP Morgan giving Neutral rating on 16-Sep-15.
In the past 6 months, 0 Insider purchases and 18 Insider Sales were made in which 7434750 shares were exchanged as Insider Sales.
The latest Insider trade was made on 15 Sep 2016 where Waud Capital Partners Iii L L C Beneficial Owner of More than 10% Class did a transaction type “Sell” in which 287668 shares were traded at a price of $47.74. Another insider trade includes Beneficial Owner of More than 10% Class Waud Capital Partners Ii L L C who also initiated a transaction in which 521033 shares were traded on 15 Sep 2016 as “Sell”.
Acadia Healthcare Company, Inc. provides inpatient behavioral health care services. It provides psychiatric and chemical dependency services, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. Acadia Healthcare Company, Inc. is headquartered in Franklin, Tennessee.